Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 12Oropharyngeal Neoplasms 12Prostatic Neoplasms 11Head and Neck Neoplasms 7Nasopharyngeal Carcinoma 6Carcinoma, Squamous Cell 6Esophageal Neoplasms 5Rectal Neoplasms 4Mouth Neoplasms 4Laryngeal Neoplasms 4Glioma 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Oligodendroglioma 2Myelodysplastic Syndromes 2Lymphatic Metastasis 2Leukemia, Myeloid, Acute 2Hypopharyngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Astrocytoma 2Anus Neoplasms 2Virus Diseases 1Vaginal Neoplasms 1

Interventions

haloperidol decanoate 1fludarabine phosphate 1fludarabine 1Temozolomide 1Surveys and Questionnaires 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Lorazepam 1Dexamethasone 1Cyclophosphamide 1Bendamustine Hydrochloride 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neurotoxicity Syndromes × Radiotherapy, Intensity-Modulated × Clear all
NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡